In the latest episode of the NextGen VC podcast, hosts and Wilson Sonsini partners Jen Fang and Mike Hostetler are joined by Xontogeny founder and biopharma veteran Chris Garabedian to discuss the transformative impact of early-stage biotech investment. Chris shares his journey from biotech corporate leadership to venture capital, emphasizing the importance of thoughtful drug development and the value of nurturing early-stage companies. He explains the inception of Xontogeny, its collaboration with Perceptive Advisors, and the unique venture incubation model they follow. Chris also highlights the essential qualities for success in biotech investing and offers insights for budding entrepreneurs and potential VCs alike.

The NextGen VC Podcast unpacks the opportunities, challenges, and breakthroughs shaping life sciences investing. It is curated by Wilson Sonsini and LaunchBio with hosts Mike Hostetler and Jen Fang. The podcast episodes feature interviews with successful venture capitalists, allowing listeners to gain wisdom from their experiences and learn how the pros have navigated challenges, made strategic decisions, and achieved remarkable success.

Click here to listen to the podcast.